Cutaneous malignancy and human immunodeficiency virus disease

Journal of the American Academy of Dermatology

Volumn 54, Issue 2, 2006, Pages 189-206

  Wilkins, Karl ^a,c   Turner, Ryan ^b   Dolev, Jacqueline C ^a   LeBoit, Philip E ^a   Berger, Timothy G ^a   Maurer, Toby A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALPHA INTERFERON; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; ATAZANAVIR; CD30 ANTIGEN; DAUNORUBICIN; DELAVIRDINE; DIDANOSINE; DOXORUBICIN; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PACLITAXEL; PEGINTERFERON ALPHA2B; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; UNINDEXED DRUG; VINCA ALKALOID; ZALCITABINE; ZIDOVUDINE;

BASAL CELL CARCINOMA; CANCER SURVIVAL; CUTANEOUS T CELL LYMPHOMA; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LYMPHOMA; MELANOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

ALGORITHMS; ANIMALS; ANTI-RETROVIRAL AGENTS; ANUS NEOPLASMS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL, KI-1; LYMPHOMA, T-CELL, CUTANEOUS; MELANOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; SKIN NEOPLASMS;

EID: 31344469080     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.11.060     Document Type: Review

References (274)

1. F.J. Palella Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, and G.A. Satten Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 1998 853 860
2. A. Mocroft, S. Vella, T.L. Benfield, A. Chiesi, V. Miller, and P. Gargalianos Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group Lancet 352 1998 1725 1730
3. K. Porter, A. Babiker, K. Bhaskaran, J. Darbyshire, P. Pezzotti, and A.S. Walker Determinants of survival following HIV-1 seroconversion after the introduction of HAART Lancet 362 2003 1267 1274
4. S. Franceschi, L. Dal Maso, S. Arniani, P. Crosignani, M. Vercelli, and L. Simonato Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study Br J Cancer 78 1998 966 970
5. G.G. Giordano, L. Sigalotti, and M. Maio New dimensions in cancer biology and therapy J Cell Physiol 183 2000 284 287
6. C. Smith, S. Lilly, K.P. Mann, E. Livingston, S. Myers, and H.K. Lyerly AIDS-related malignancies Ann Med 30 1998 323 344
7. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults J Natl Cancer Inst 92 2000 1823 1830
8. B. Cribier, Y. Scrivener, and E. Grosshans Molluscum contagiosum: histologic patterns and associated lesions. A study of 578 cases Am J Dermatopathol 23 2001 99 103
9. I. Penn Cancers in renal transplant recipients Adv Ren Replace Ther 7 2000 147 156
10. D.K. Ohashi, J.S. Crane, T.J. Spira, and M.L. Courrege Idiopathic CD4+ T-cell lymphocytopenia with verrucae, basal cell carcinomas, and chronic tinea corporis infection J Am Acad Dermatol 31 1994 889 891
11. T. Hayashi, Y. Hinoda, T. Takahashi, M. Adachi, S. Miura, and T. Izumi Idiopathic CD4+ T-lymphocytopenia with Bowen's disease Intern Med 36 1997 822 824
12. K.M. Bang, and C.A. Laing Lymphocytopenia in high cancer risk population: evidence in automobile pattern makers Cancer Lett 30 1986 311 314
13. R. Paolini, E. D'Andrea, A. Poletti, A. Del Mistro, P. Zerbinati, and A. Girolami B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia Leuk Lymphoma 21 1996 177 180
14. J.W. Cohen Stuart, M.D. Hazebergh, D. Hamann, S.A. Otto, J.C. Borleffs, and F. Miedema The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation J Acquir Immune Defic Syndr 25 2000 203 211
15. O. Beran, M. Holub, J. Spala, J. Kalanin, and M. Stankova Cd38 expression on Cd8+ T cells in human immunodeficiency virus 1-positive adults treated with HAART Acta Virol 47 2003 121 124
16. J.V. Giorgi, L.E. Hultin, J.A. McKeating, T.D. Johnson, B. Owens, and L.P. Jacobson Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage J Infect Dis 179 1999 859 870
17. Z. Grossman, M. Meier-Schellersheim, A.E. Sousa, R.M. Victorino, and W.E. Paul CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 8 2002 319 323
18. P.W. Hunt, J.N. Martin, E. Sinclair, B. Bredt, E. Hagos, and H. Lampiris T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy J Infect Dis 187 2003 1534 1543
19. P. Robertson, and D.T. Scadden Immune reconstitution in HIV infection and its relationship to cancer Hematol Oncol Clin North Am 17 2003 703 716 vi
20. E.C. Breen, W.J. Boscardin, R. Detels, L.P. Jacobson, M.W. Smith, and S.J. O'Brien Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter-592 C/C genotype Clin Immunol 109 2003 119 129
21. A.G. Dalgleish, and K.J. O'Byrne Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer Adv Cancer Res 84 2002 231 276
22. E. Weiss, A.J. Mamelak, S. La Morgia, B. Wang, C. Feliciani, and A. Tulli The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases J Am Acad Dermatol 50 2004 657 675 quiz, 676-8
23. C. Brigati, M. Giacca, D.M. Noonan, and A. Albini HIV tat, its targets and the control of viral gene expression FEMS Microbiol Lett 220 2003 57 65
24. G. Barillari, and B. Ensoli Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma Clin Microbiol Rev 15 2002 310 326
25. B.L. Wei, V.K. Arora, J.L. Foster, D.L. Sodora, and J.V. Garcia In vivo analysis of Nef function Curr HIV Res 1 2003 41 50
26. V. Piguet, L. Wan, C. Borel, A. Mangasarian, N. Demaurex, and G. Thomas HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes Nat Cell Biol 2 2000 163 167
27. K. Ferenczi, R.C. Fuhlbrigge, J. Pinkus, G.S. Pinkus, and T.S. Kupper Increased CCR4 expression in cutaneous T cell lymphoma J Invest Dermatol 119 2002 1405 1410
28. M. Spina, M. Berretta, and U. Tirelli Hodgkin's disease in HIV Hematol Oncol Clin North Am 17 2003 843 858
29. L. Dal Maso, S. Franceschi, J. Polesel, C. Braga, P. Piselli, and E. Crocetti Risk of cancer in persons with AIDS in Italy, 1985-1998 Br J Cancer 89 2003 94 100
30. A.E. Grulich, Y. Li, A. McDonald, P.K. Correll, M.G. Law, and J.M. Kaldor Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis AIDS 16 2002 1155 1161
31. D.W. Lyter, J. Bryant, R. Thackeray, C.R. Rinaldo, and L.A. Kingsley Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men J Clin Oncol 13 1995 2540 2546
32. L. Gerard, L. Galicier, E. Boulanger, L. Quint, M.G. Lebrette, and E. Mortier Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy AIDS 17 2003 81 87
33. M. Spina, J. Gabarre, G. Rossi, M. Fasan, C. Schiantarelli, and E. Nigra Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection Blood 100 2002 1984 1988
34. M. Spina, A. Re, E. Vaccher, J. Gabarre, and U. Tirelli High international prognostic score predicts a worse outcome for patients with Hodgkin's disease and HIV infection: results of a prospective study with Stanford V regimen Ann Oncol 14 2003 655 656
35. A.E. Gates, and L.D. Kaplan AIDS malignancies in the era of highly active antiretroviral therapy Oncology (Huntingt) 16 2002 657 665 discussion, 665, 668-70.
36. J.J. Goedert, T.R. Cote, P. Virgo, S.M. Scoppa, D.W. Kingma, and M.H. Gail Spectrum of AIDS-associated malignant disorders Lancet 351 1998 1833 1839
37. M.V. Ragni, S.H. Belle, R.A. Jaffe, S.L. Duerstein, D.C. Bass, and C.W. McMillan Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia Blood 81 1993 1889 1897
38. L. Dal Maso, and S. Franceschi Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS Lancet Oncol 4 2003 110 119
39. O. Kirk, C. Pedersen, A. Cozzi-Lepri, F. Antunes, V. Miller, and J.M. Gatell Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy Blood 98 2001 3406 3412
40. C. Thirlwell, D. Sarker, J. Stebbing, and M. Bower Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy Clin Lymphoma 4 2003 86 92
41. R.F. Little, M. Gutierrez, E.S. Jaffe, A. Pau, M. Horne, and W. Wilson HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis JAMA 285 2001 1880 1885
42. U. Tirelli, M. Spina, G. Gaidano, E. Vaccher, S. Franceschi, and A. Carbone Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy AIDS 14 2000 1675 1688
43. L.D. Kaplan, D.I. Abrams, E. Feigal, M. McGrath, J. Kahn, and P. Neville AIDS-associated non-Hodgkin's lymphoma in San Francisco JAMA 261 1989 719 724
44. C. Hoffmann, E. Wolf, G. Fatkenheuer, T. Buhk, A. Stoehr, and A. Plettenberg Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma AIDS 17 2003 1521 1529
45. J.T. Navarro, J.M. Ribera, A. Oriol, J. Romeu, G. Sirera, and J.L. Mate Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma Leuk Lymphoma 43 2002 1837 1842
46. J.T. Navarro, J.M. Ribera, A. Oriol, C. Tural, F. Milla, and E. Feliu Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy J Acquir Immune Defic Syndr 32 2003 347 348
47. J.M. Ribera, J.T. Navarro, A. Oriol, A. Lopez-Guillermo, A. Sureda, and E. Abella Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease AIDS 16 2002 1973 1976
48. L. Gerard, L. Galicier, A. Maillard, E. Boulanger, L. Quint, and S. Matheron Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival J Acquir Immune Defic Syndr 30 2002 478 484
49. E. Oksenhendler, J.P. Clauvel, S. Jouveshomme, F. Davi, and G. Mansour Complete remission of a primary effusion lymphoma with antiretroviral therapy Am J Hematol 57 1998 266
50. G. Fatkenheuer, K. Hell, A. Roers, V. Diehl, and B. Salzberger Spontaneous regression of HIV-associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy Eur J Med Res 5 2000 236 240
51. M. Beylot-Barry, B. Vergier, B. Masquelier, M. Bagot, P. Joly, and P. Souteyrand The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases Am J Surg Pathol 23 1999 1208 1216
52. K.P. Mann, B. Hall, H. Kamino, M.J. Borowitz, and H. Ratech Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma Am J Surg Pathol 19 1995 407 416
53. D.N. Jhala, L.J. Medeiros, D. Lopez-Terrada, N.C. Jhala, B. Krishnan, and I. Shahab Neutrophil-rich anaplastic large cell lymphoma of T-cell lineage. A report of two cases arising in HIV-positive patients Am J Clin Pathol 114 2000 478 482
54. A. Chadburn, E. Cesarman, J. Jagirdar, M. Subar, R.N. Mir, and D.M. Knowles CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus Cancer 72 1993 3078 3090
55. A.W. Funkhouser, P.J. Katzman, J.Z. Sickel, and J.S. Lambert CD30-positive anaplastic large cell lymphoma (ALCL) of T-cell lineage in a 14-month-old infant with perinatally acquired HIV-1 infection J Pediatr Hematol Oncol 20 1998 556 559
56. R.L. Kerschmann, T.G. Berger, L.M. Weiss, B.G. Herndier, K.M. Abrahms, and V. Heon Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage Arch Dermatol 131 1995 1281 1288
57. G. Macgrogan, B. Vergier, P. Dubus, M. Beylot-Barry, G. Belleannee, and M.M. Delaunay CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases Am J Clin Pathol 105 1996 440 450
58. A.N. Davies, and H.J. Dobbs Isolated cutaneous relapse in Hodgkin's disease: a case report and review of the literature Clin Oncol (R Coll Radiol) 5 1993 120 121
59. K. Nakamura, H. Katano, Y. Hoshino, T. Nakamura, O. Hosono, and A. Masunaga Human herpesvirus type 8 and Epstein-Barr virus-associated cutaneous lymphoma taking anaplastic large cell morphology in a man with HIV infection Br J Dermatol 141 1999 141 145
60. R. Willemze, and R.C. Beljaards Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment J Am Acad Dermatol 28 1993 973 980
61. R. Willemze, P. Kaudewitz, and E. Berti Primary cutaneous CD30 (Ki-1) positive large cell lymphomas: definition and differential diagnostic aspects W.C. Lambert Basic mechanisms of physiologic and aberrant lymphoproliferation in the skin 1994 Plenum Press New York 265 273
62. R. Willemze, H. Kerl, W. Sterry, E. Berti, L. Cerroni, and S. Chimenti EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer Blood 90 1997 354 371
63. G. Burg, W. Kempf, D.V. Kazakov, R. Dummer, P.J. Frosch, and S. Lange-Ionescu Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature Br J Dermatol 148 2003 580 586
64. M.W. Bekkenk, F.A. Geelen, P.C. van Voorst Vader, F. Heule, M.L. Geerts, and W.A. van Vloten Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment Blood 95 2000 3653 3661
65. R.C. Beljaards, P. Kaudewitz, E. Berti, R. Gianotti, C. Neumann, and R. Rosso Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients Cancer 71 1993 2097 2104
66. T.A. Maurer, H.S. Zackheim, L. Tuffanelli, and T.G. Berger The use of methotrexate for treatment of psoriasis in patients with HIV infection J Am Acad Dermatol 31 1994 372 375
67. D. Neau, P. Trimoulet, M. Winnock, A. Rullier, B. Le Bail, and D. Lacoste Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients Clin Infect Dis 36 2003 1564 1571
68. A. Hatzakis, P. Gargalianos, V. Kiosses, M. Lazanas, V. Sypsa, and C. Anastassopoulou Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication J Interferon Cytokine Res 21 2001 861 869
69. H. Bachelez, F. Hadida, and G. Gorochov Massive infiltration of the skin by HIV-specific cytotoxic CD8+ T cells N Engl J Med 335 1996 61 62
70. S. Friedler, M.T. Parisi, E. Waldo, R. Wieczorek, G. Sidhu, and M.J. Rico Atypical cutaneous lymphoproliferative disorder in patients with HIV infection Int J Dermatol 38 1999 111 118
71. M. Janier, C. Katlama, B. Flageul, F. Valensi, I. Moulonguet, and F. Sigaux The pseudo-Sezary syndrome with CD8 phenotype in a patient with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med 110 1989 738 740
72. C. Picard-Dahan, T. Le Guyadec, M. Grossin, N. Feton, M. Raphael, and A.M. Simonpoli [Pigmented erythroderma in AIDS. 5 cases] Ann Dermatol Venereol 123 1996 307 313
73. P. Zhang, L. Chiriboga, M. Jacobson, E. Marsh, P. Hennessey, and R. Schinella Mycosis fungoideslike T-cell cutaneous lymphoid infiltrates in patients with HIV infection Am J Dermatopathol 17 1995 29 35
74. D. Zucker-Franklin, B.A. Pancake, and A.E. Friedman-Kien Cutaneous disease resembling mycosis fungoides in HIV-infected patients whose skin and blood cells also harbor proviral HTLV type I AIDS Res Hum Retroviruses 10 1994 1173 1177
75. T.G. Berger, R.L. Kerschmann, R. Roth, K. Schulze, and H.S. Zackheim Sezary's syndrome and human immunodeficiency virus infection Arch Dermatol 131 1995 739 741
76. S.C. Parker, D.A. Fenton, and D.H. McGibbon Homme rouge and the acquired immunodeficiency syndrome N Engl J Med 321 1989 906 907
77. M.H. Kaplan, W.W. Hall, M. Susin, S. Pahwa, S.Z. Salahuddin, and C. Heilman Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection Am J Med 91 1991 300 309
78. J. Guitart, D. Variakojis, T. Kuzel, and S. Rosen Cutaneous CD8 T cell infiltrates in advanced HIV infection J Am Acad Dermatol 41 1999 722 727
79. M.K. Burns, and K.D. Cooper Cutaneous T-cell lymphoma associated with HIV infection J Am Acad Dermatol 29 1993 394 399
80. G.A. Crane, D. Variakojis, S.T. Rosen, A.M. Sands, and H.H. Roenigk Jr. Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection Arch Dermatol 127 1991 989 994
81. J. Goldstein, N. Becker, J. DelRowe, and L. Davis Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1. Use of radiation therapy Cancer 66 1990 1130 1132
82. P.E. LeBoit, H.S. Zackheim, and C.R. White Jr. Granulomatous variants of cutaneous T-cell lymphoma. The histopathology of granulomatous mycosis fungoides and granulomatous slack skin Am J Surg Pathol 12 1988 83 95
83. T.A. Longacre, K. Foucar, F. Koster, and W. Burgdorf Atypical cutaneous lymphoproliferative disorder resembling mycosis fungoides in AIDS. Report of a case with concurrent Kaposi's sarcoma Am J Dermatopathol 11 1989 451 456
84. M.A. Munoz-Perez, J.J. Rios-Martin, A. Rodriguez-Pichardo, and F. Camacho Cutaneous T-cell lymphoma and human immunodeficiency virus infection: 2 cases and a review of the literature Acta Derm Venereol 79 1999 153 155
85. B. Poiesz, D. Dube, S. Dube, J. Love, L. Papsidero, and A. Uner HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection N Engl J Med 342 2000 930 936
86. T. Sorrells, L. Pratt, J. Newton, S. Graham, and M. Ryan Spontaneous regression of granulomatous mycosis fungoides in an HIV positive patient J Am Acad Dermatol 37 1997 876 880
87. G.T. Nahass, C.A. Kraffert, and N.S. Penneys Cutaneous T-cell lymphoma associated with the acquired immunodeficiency syndrome Arch Dermatol 127 1991 1020 1022
88. N. Yawalker, K. Ferenczi, D.A. Jones, K. Yamanaka, K.Y. Suh, and S. Sadat Profound loss of T cell receptor repertoire complexity in cutaneous T cell lymphoma Blood 102 2003 4059 4066
89. H. Bachelez, F. Hadida, C. Parizot, B. Flageul, M. Kemula, and L. Dubertret Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma J Clin Invest 101 1998 2506 2516
90. S.A. Nasr, R.K. Brynes, C.P. Garrison, and W.C. Chan Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome Cancer 61 1988 947 951
91. K. Jimbow, and L.D. Jewell Lymphoid proliferation and lymphoma associated with human retroviruses (HTLV and HIV) Int J Dermatol 30 1991 605 613
92. J. Guitart HIV-1 and an HTLV-II-associated cutaneous T-cell lymphoma N Engl J Med 343 2000 303 304
93. T.P. Cooley Non-AIDS-defining cancer in HIV-infected people Hematol Oncol Clin North Am 17 2003 889 899
94. H. Rasokat, G.K. Steigleder, C. Bendick, S. Muller, and M. Meller [Malignant melanoma and HIV infection] Z Hautkr 64 1989 581 582 587
95. D. Calista Five cases of melanoma in HIV positive patients Eur J Dermatol 11 2001 446 449
96. R.K. Solomon, S.J. Lundeen, D.D. Hamlar, and S.E. Pambuccian Fine-needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients: a report of two cases and review of the literature Diagn Cytopathol 24 2001 186 192
97. J.M. McGregor, M. Newell, J. Ross, N. Kirkham, D.H. McGibbon, and C. Darley Cutaneous malignant melanoma and human immunodeficiency virus (HIV) infection: a report of three cases Br J Dermatol 126 1992 516 519
98. D. Massi, L. Borgognoni, U.M. Reali, and A. Franchi Malignant melanoma associated with human immunodeficiency virus infection: a case report and review of the literature Melanoma Res 8 1998 187 192
99. P. Gattuso, L. Kluskens, V. Reddy, L. Green, H. Attal, and G. Yu Fine needle aspiration of solid tumors in HIV-positive patients Acta Cytol 43 1999 510 512
100. G.M. Kind, J. VonRoenn, D.A. Jansen, M.H. Bailey, and V.L. Lewis Jr. Human immunodeficiency virus infection and subsequent melanoma Ann Plast Surg 37 1996 273 277
101. W. Krause, H. Mittag, U. Gieler, E. Thomas, and U. Wichmann A case of malignant melanoma in AIDS-related complex Arch Dermatol 123 1987 867 868
102. J.K. Rivers, A.W. Kopf, and A.H. Postel Malignant melanoma in a man seropositive for the human immunodeficiency virus J Am Acad Dermatol 20 1989 1127 1128
103. D.M. Aboulafia Malignant melanoma in an HIV-infected man: a case report and literature review Cancer Invest 16 1998 217 224
104. C.J. van Ginkel, R.T. Sang, J.L. Blaauwgeers, J.K. Schattenkerk, W.J. Mooi, and H.J. Hulsebosch Multiple primary malignant melanomas in an HIV-positive man J Am Acad Dermatol 24 1991 284 285
105. F. Pereira, W. Carey, H. Shibata, M.N. Burnier Jr., and B. Wang Multiple nevoid malignant melanomas in a patient with AIDS: the role of proliferating cell nuclear antigen in the diagnosis J Am Acad Dermatol 47 suppl 2002 S172 S174
106. K.J. Smith, H.G. Skelton, J. Yeager, P. Angritt, and K.F. Wagner Cutaneous neoplasms in a military population of HIV-1-positive patients. Military Medical Consortium for the Advancement of Retroviral Research J Am Acad Dermatol 29 1993 400 406
107. B. Tindall, R. Finlayson, K. Mutimer, F.A. Billson, V.F. Munro, and D.A. Cooper Malignant melanoma associated with human immunodeficiency virus infection in three homosexual men J Am Acad Dermatol 20 1989 587 591
108. L.K. Rodrigues, B.J. Klencke, K. Vin-Christian, T.G. Berger, R.I. Crawford, and J.R. Miller III Altered clinical course of malignant melanoma in HIV-positive patients Arch Dermatol 138 2002 765 770
109. H. Tsao, M.B. Atkins, and A.J. Sober Management of cutaneous melanoma N Engl J Med 351 2004 998 1012
110. A.J. Sober, T.Y. Chuang, M. Duvic, E.R. Farmer, J.M. Grichnik, and A.C. Halpern Guidelines of care for primary cutaneous melanoma J Am Acad Dermatol 45 2001 579 586
111. R.P. Myers, Y. Benhamou, M. Bochet, V. Thibault, D. Mehri, and T. Poynard Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy AIDS 18 2004 75 79
112. J.A. Kovacs, S. Vogel, J.A. Metcalf, M. Baseler, R. Stevens, and J. Adelsberger Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy Eur J Immunol 31 2001 1351 1360
113. R. Mitsuyasu Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients J Infect Dis 185 Suppl 2 2002 S115 S122
114. H. Tsao, S.R. Tahan, and R.A. Johnson Chronic varicella zoster infection mimicking a basal cell carcinoma in an AIDS patient J Am Acad Dermatol 36 1997 831 833
115. G.J. Murakawa, T.M. Mauro, and B. Egbert Disseminated cutaneous Cryptococcus clinically mimicking basal cell carcinoma Dermatol Surg 21 1995 992 993
116. T.A. Maurer, K.V. Christian, R.L. Kerschmann, B. Berzin, J.M. Palefsky, and D. Payne Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression Arch Dermatol 133 1997 577 583
117. D.V. Lobo, P. Chu, R.C. Grekin, and T.G. Berger Nonmelanoma skin cancers and infection with the human immunodeficiency virus Arch Dermatol 128 1992 623 627
118. Y. Oram, I. Orengo, R.D. Griego, T. Rosen, and J. Thornby Histologic patterns of basal cell carcinoma based upon patient immunostatus Dermatol Surg 21 1995 611 614
119. K.V. Sitz, M. Keppen, and D.F. Johnson Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex JAMA 257 1987 340 343
120. M.H. Kagen, R.J. Hirsch, P. Chu, P.C. McCormack, and J.M. Weinberg Multiple infundibulocystic basal cell carcinomas in association with human immunodeficiency virus J Cutan Pathol 27 2000 316 318
121. A. Rahimizadeh, R. Shelton, H. Weinberg, and N. Sadick The development of a Marjolin's cancer in a human immunodeficiency virus-positive hemophilic man and review of the literature Dermatol Surg 23 1997 560 563
122. K.E. Warschaw, J.N. Eble, A.F. Hood, S.E. Wolverton, and K.C. Halling The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies J Cutan Pathol 24 1997 511 518
123. L.U. Wolfer, U. Blume-Peytavi, B. Almond-Roesler, H. Gollnick, and C.E. Orfanos [Transformation of multiple basaliomas to squamous cell carcinomas in an HIV patient with Gorlin-Goltz syndrome] Hautarzt 46 1995 268 271
124. E. Alamartine, and F. Berthoux [Oncological complications after renal transplantation] Presse Med 20 1991 891 895
125. T.G. Berger, W.S. Sawchuk, C. Leonardi, A. Langenberg, J. Tappero, and P.E. Leboit Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease Br J Dermatol 124 1991 79 83
126. M. Alam, J.B. Caldwell, and Y.D. Eliezri Human papillomavirus-associated digital squamous cell carcinoma: literature review and report of 21 new cases J Am Acad Dermatol 48 2003 385 393
127. W.A. High, S.K. Tyring, and R.S. Taylor Rapidly enlarging growth of the proximal nail fold Dermatol Surg 29 2003 984 986
128. T.A. Maurer, K.V. Christian, R.L. Kerschmann, B. Berzin, J.M. Palefsky, and D. Payne Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression Arch Dermatol 133 1997 577 583
129. C.A. Harwood, J.M. McGregor, C.M. Proby, and J. Breuer Human papillomavirus and the development of non-melanoma skin cancer J Clin Pathol 52 1999 249 253
130. A.P. Black, and G.S. Ogg The role of p53 in the immunobiology of cutaneous squamous cell carcinoma Clin Exp Immunol 132 2003 379 384
131. T. Mitsuishi, S. Kawana, T. Kato, and M. Kawashima Human papillomavirus infection in actinic keratosis and bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions Hum Pathol 34 2003 886 892
132. P. Nguyen, K. Vin-Christian, M.E. Ming, and T. Berger Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus Arch Dermatol 138 2002 758 763
133. P. Nguyen, K. Vin-Christian, M.E. Ming, and T. Berger Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus Arch Dermatol 138 2002 758 763
134. J.R. Daling, N.S. Weiss, T.G. Hislop, C. Maden, R.J. Coates, and K.J. Sherman Sexual practices, sexually transmitted diseases, and the incidence of anal cancer N Engl J Med 317 1987 973 977
135. G. Berry, M. Billingham, E. Alderman, P. Richardson, F. Torti, and B. Lum The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin Ann Oncol 9 1998 711 716
136. A.J. Durante, A.B. Williams, M. Da Costa, T.M. Darragh, K. Khoshnood, and J.M. Palefsky Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women Cancer Epidemiol Biomarkers Prev 12 2003 638 642
137. M. Frisch, R.J. Biggar, and J.J. Goedert Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome J Natl Cancer Inst 92 2000 1500 1510
138. J.M. Palefsky, E.A. Holly, M.L. Ralston, S.P. Arthur, N. Jay, and J.M. Berry Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors J Acquir Immune Defic Syndr Hum Retrovirol 17 1998 320 326
139. P.V. Chin-Hong, and J.M. Palefsky Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus Clin Infect Dis 35 2002 1127 1134
140. J.M. Palefsky, E.A. Holly, M.L. Ralston, and N. Jay Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men J Infect Dis 177 1998 361 367
141. J.M. Palefsky, E.A. Holly, M.L. Ralston, M. Da Costa, and R.M. Greenblatt Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women J Infect Dis 183 2001 383 391
142. J.M. Palefsky, E.A. Holly, M.L. Ralston, N. Jay, J.M. Berry, and T.M. Darragh High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men AIDS 12 1998 495 503
143. N. Kiviat, A. Rompalo, R. Bowden, D. Galloway, K.K. Holmes, and L. Corey Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative men J Infect Dis 162 1990 358 361
144. A.B. Williams, T.M. Darragh, K. Vranizan, C. Ochia, A.R. Moss, and J.M. Palefsky Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women Obstet Gynecol 83 1994 205 211
145. J.M. Palefsky, E.A. Holly, M.L. Ralston, N. Jay, J.M. Berry, and T.M. Darragh High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men AIDS 12 1998 495 503
146. A. Schafer, W. Friedmann, M. Mielke, B. Schwartlander, and M.A. Koch The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression Am J Obstet Gynecol 164 1991 593 599
147. I. Arany, T. Evans, and S.K. Tyring Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals Sex Transm Infect 74 1998 349 353
148. I. Arany, A. Yen, and S.K. Tyring p53, WAF1/CIP1 and mdm2 expression in skin lesions associated with human papillomavirus and human immunodeficiency virus Anticancer Res 17 1997 1281 1285
149. A. Dolei, S. Curreli, P. Marongiu, A. Pierangeli, E. Gomes, and M. Bucci Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein J Gen Virol 80 Pt 11 1999 2937 2944
150. J.M. Palefsky, E.A. Holly, M.L. Ralston, M. Da Costa, H. Bonner, and N. Jay Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection J Acquir Immune Defic Syndr 28 2001 422 428
151. J.M. Palefsky Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women Semin Oncol 27 2000 471 479
152. P. Fox, J. Stebbing, S. Portsmouth, A. Winston, N. Frances, and M. Nelson Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy AIDS 17 2003 279 280
153. J.M. Palefsky Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection J Acquir Immune Defic Syndr 21 Suppl 1 1999 S42 S48
154. J.M. Palefsky Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women Semin Oncol 27 2000 471 479
155. J.M. Palefsky, E.A. Holly, C.J. Hogeboom, J.M. Berry, N. Jay, and T.M. Darragh Anal cytology as a screening tool for anal squamous intraepithelial lesions J Acquir Immune Defic Syndr Hum Retrovirol 14 1997 415 422
156. P.V. Chin-Hong, and J.M. Palefsky Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus Clin Infect Dis 35 2002 1127 1134
157. S.J. Goldie, K.M. Kuntz, M.C. Weinstein, K.A. Freedberg, M.L. Welton, and J.M. Palefsky The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men JAMA 281 1999 1822 1829
158. L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, and F.B. Alvarez A controlled trial of a human papillomavirus type 16 vaccine N Engl J Med 347 2002 1645 1651
159. S. Franceschi, S. Arniani, D. Balzi, and M. Geddes Survival of classic Kaposi's sarcoma and risk of second cancer Br J Cancer 74 1996 1812 1814
160. H.K. Tam, Z.F. Zhang, L.P. Jacobson, J.B. Margolick, J.S. Chmiel, and C. Rinaldo Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma Int J Cancer 98 2002 916 922
161. U. Tirelli, and D. Bernardi Impact of HAART on the clinical management of AIDS-related cancers Eur J Cancer 37 2001 1320 1324
162. J.L. Jones, D.L. Hanson, M.S. Dworkin, and H.W. Jaffe Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy J Acquir Immune Defic Syndr 24 2000 270 274
163. G. Borroni, V. Brazzelli, G.P. Vignoli, and M.R. Gaviglio Bullous lesions in Kaposi's sarcoma: case report Am J Dermatopathol 19 1997 379 383
164. A. Russo [Unifocal skin location of Kaposi's sarcoma, mimicking melanoma: the role of excisional biopsy for the timely identification of an unusual pathology with potential fatal prognosis] G Chir 22 2001 285 289
165. V. Beral, T.A. Peterman, R.L. Berkelman, and H.W. Jaffe Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335 1990 123 128
166. Y. Chang, E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, and D.M. Knowles Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
167. J.J. Russo, R.A. Bohenzky, M.C. Chien, J. Chen, M. Yan, and D. Maddalena Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) Proc Natl Acad Sci USA 93 1996 14862 14867
168. C. Boshoff, and Y. Chang Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus Annu Rev Med 52 2001 453 470
169. C.C. Marchioli, J.L. Love, L.Z. Abbott, Y.Q. Huang, S.C. Remick, and N. Surtento-Reodica Prevalence of human herpesvirus 8 DNA sequences in several patient populations J Clin Microbiol 34 1996 2635 2638
170. T.B. Campbell, M. Borok, L. Gwanzura, S. MaWhinney, I.E. White, and B. Ndemera Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage AIDS 14 2000 2109 2116
171. C. Lebbe, F. Agbalika, P. de Cremoux, M. Deplanche, M. Rybojad, and E. Masgrau Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma Arch Dermatol 133 1997 25 30
172. V. Boneschi, L. Brambilla, E. Berti, S. Ferrucci, M. Corbellino, and C. Parravicini Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlations Dermatology 203 2001 19 23
173. D. Whitby, M.R. Howard, M. Tenant-Flowers, N.S. Brink, A. Copas, and C. Boshoff Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma Lancet 346 1995 799 802
174. D.M. Koelle, M.L. Huang, B. Chandran, J. Vieira, M. Piepkorn, and L. Corey Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates J Infect Dis 176 1997 94 102
175. J. Vieira, M.L. Huang, D.M. Koelle, and L. Corey Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma J Virol 71 1997 7083 7087
176. J. Pauk, M.L. Huang, S.J. Brodie, A. Wald, D.M. Koelle, and T. Schacker Mucosal shedding of human herpesvirus 8 in men N Engl J Med 343 2000 1369 1377
177. J.R. LaDuca, J.L. Love, L.Z. Abbott, S. Dube, A.E. Freidman-Kien, and B.J. Poiesz Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids J Infect Dis 178 1998 1610 1615
178. M.R. Howard, D. Whitby, G. Bahadur, F. Suggett, C. Boshoff, and M. Tenant-Flowers Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors AIDS 11 1997 F15 F19
179. T. Tasaka, J.W. Said, R. Morosetti, D. Park, W. Verbeek, and M. Nagai Is Kaposi's sarcoma-associated herpesvirus ubiquitous in urogenital and prostate tissues? Blood 89 1997 1686 1689
180. P.E. Pellett, T.J. Spira, O. Bagasra, C. Boshoff, L. Corey, and L. de Lellis Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen J Clin Microbiol 37 1999 1298 1301
181. L. Brambilla, V. Boneschi, S. Ferrucci, M. Taglioni, and E. Berti Human herpesvirus-8 infection among heterosexual partners of patients with classical Kaposi's sarcoma Br J Dermatol 143 2000 1021 1025
182. R. Tedeschi, L. Caggiari, I. Silins, I. Kallings, A. Andersson-Ellstrom, and P. De Paoli Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women Int J Cancer 87 2000 232 235
183. C.S. Rabkin, J.J. Goedert, R.J. Biggar, F. Yellin, and W.A. Blattner Kaposi's sarcoma in three HIV-1-infected cohorts J Acquir Immune Defic Syndr 3 Suppl 1 1990 S38 S43
184. J.N. Martin, D.E. Ganem, D.H. Osmond, K.A. Page-Shafer, D. Macrae, and D.H. Kedes Sexual transmission and the natural history of human herpesvirus 8 infection N Engl J Med 338 1998 948 954
185. C. Casper, A. Wald, J. Pauk, S.R. Tabet, L. Corey, and C.L. Celum Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men J Infect Dis 185 2002 990 993
186. G. Rezza, M. Andreoni, M. Dorrucci, P. Pezzotti, P. Monini, and R. Zerboni Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases J Natl Cancer Inst 91 1999 1468 1474
187. F. Vitale, E. Viviano, A.M. Perna, F. Bonura, G. Mazzola, and F. Ajello Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8) Epidemiol Infect 125 2000 671 675
188. P. Cattani, M. Capuano, F. Cerimele, I.L. La Parola, R. Santangelo, and C. Masini Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma J Clin Microbiol 37 1999 1150 1153
189. P. Cattani, F. Cerimele, D. Porta, R. Graffeo, S. Ranno, and S. Marchetti Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions Clin Microbiol Infect 9 2003 274 279
190. D. Bourboulia, D. Whitby, C. Boshoff, R. Newton, V. Beral, and H. Carrara Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection JAMA 280 1998 31 32
191. S. Mayama, L.E. Cuevas, J. Sheldon, O.H. Omar, D.H. Smith, and P. Okong Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents Int J Cancer 77 1998 817 820
192. K. Antman, and Y. Chang Kaposi's sarcoma N Engl J Med 342 2000 1027 1038
193. D. Serraino, L. Toma, M. Andreoni, S. Butto, O. Tchangmena, and L. Sarmati A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and central Africa and in the Mediterranean area Eur J Epidemiol 17 2001 871 876
194. J.N. Martin, and D.H. Osmond Invited commentary: determining specific sexual practices associated with human herpesvirus 8 transmission Am J Epidemiol 151 2000 225 229 discussion, 230
195. S.J. Gao, M. Alsina, J.H. Deng, C.R. Harrison, E.A. Montalvo, and C.T. Leach Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma J Infect Dis 178 1998 846 849
196. G.R. Simpson, T.F. Schulz, D. Whitby, P.M. Cook, C. Boshoff, and L. Rainbow Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen Lancet 348 1996 1133 1138
197. M. Cannon, and E. Cesarman Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy Semin Oncol 27 2000 409 419
198. C. Boshoff, T.F. Schulz, M.M. Kennedy, A.K. Graham, C. Fisher, and A. Thomas Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells Nat Med 1 1995 1274 1278
199. J.J. Brooks Kaposi's sarcoma: a reversible hyperplasia Lancet 2 1986 1309 1311
200. M. Janier, M.D. Vignon, and F. Cottentot Spontaneously healing Kaposi's sarcoma in AIDS N Engl J Med 312 1985 1638 1639
201. S.J. Gao, L. Kingsley, D.R. Hoover, T.J. Spira, C.R. Rinaldo, and A. Saah Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma N Engl J Med 335 1996 233 241
202. N. Renwick, T. Halaby, G.J. Weverling, N.H. Dukers, G.R. Simpson, and R.A. Coutinho Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma AIDS 12 1998 2481 2488
203. C. Boshoff, and R.A. Weiss Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus Philos Trans R Soc Lond B Biol Sci 356 2001 517 534
204. C.B. Foster, T. Lehrnbecher, S. Samuels, S. Stein, F. Mol, and J.A. Metcalf An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus Blood 96 2000 2562 2567
205. M. Montella, S. Franceschi, M. Geddes, S. Arniani, and G. Cocchiarella Classic Kaposi's sarcoma and volcanic soil in southern Italy Lancet 347 1996 905
206. R.J. Biggar AIDS-related cancers in the era of highly active antiretroviral therapy Oncology (Huntingt) 15 2001 439 448 discussion, 448-9
207. C. Dupont, E. Vasseur, A. Beauchet, P. Aegerter, H. Berthe, and P. de Truchis Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodeficience humaine AIDS 14 2000 987 993
208. H. Leitch, M. Trudeau, and J.P. Routy Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy HIV Clin Trials 4 2003 107 114
209. M.A. Conant, K.M. Opp, D. Poretz, and R.G. Mills Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir AIDS 11 1997 1300 1301
210. M. Murphy, D. Armstrong, K.A. Sepkowitz, R.N. Ahkami, and P.L. Myskowski Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor AIDS 11 1997 261 262
211. M. Bower, P. Fox, K. Fife, J. Gill, M. Nelson, and B. Gazzard Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma AIDS 13 1999 2105 2111
212. G. Murdaca, A. Campelli, M. Setti, F. Indiveri, and F. Puppo Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor AIDS 16 2002 304 305
213. J. Krischer, O. Rutschmann, B. Hirschel, S. Vollenweider-Roten, J.H. Saurat, and M. Pechere Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study J Am Acad Dermatol 38 1998 594 598
214. N. Dupin, V. Rubin De Cervens, I. Gorin, V. Calvez, E. Pessis, and M. Grandadam The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma Br J Dermatol 140 1999 875 881
215. A. Cattelan, M. Calabro, P. Gasperini, S. Aversa, M. Zanchetta, and F. Meneghetti Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome J Natl Cancer Inst Monogr 28 2001 44 49
216. C. Pellet, S. Chevret, L. Blum, C. Gauville, M. Hurault, and G. Blanchard Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy J Invest Dermatol 117 2001 858 863
217. C. Lebbe, L. Blum, C. Pellet, G. Blanchard, O. Verola, and P. Morel Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma AIDS 12 1998 F45 F49
218. J. Chan, S. Kravcik, and J.B. Angel Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia J Acquir Immune Defic Syndr 22 1999 209 210
219. C. Sgadari, G. Barillari, E. Toschi, D. Carlei, I. Bacigalupo, and S. Baccarini HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma Nat Med 8 2002 225 232
220. J. Stebbing, S. Portsmouth, M. Nelson, S. Mandalia, H. Kandil, and N. Alexander The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcoma Int J Cancer 108 2004 631 633
221. S. Portsmouth, J. Stebbing, J. Gill, S. Mandalia, M. Bower, and M. Nelson A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma AIDS 17 2003 F17 F22
222. European guidelines for the clinical management and treatment of HIV-infected adults in Europe AIDS 17 Suppl 2 2003 S3 S26
223. M. Dybul, A.S. Fauci, J.G. Bartlett, J.E. Kaplan, and A.K. Pau Guidelines for using antiretroviral agents among HIV-infected adults and adolescents Ann Intern Med 137 2002 381 433
224. M. Dybul, A.S. Fauci, J.G. Bartlett, J.E. Kaplan, and A.K. Pau Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV MMWR Recomm Rep 51 2002 1 55
225. P.G. Yeni, S.M. Hammer, M.S. Hirsch, M.S. Saag, M. Schechter, and C.C. Carpenter Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel JAMA 292 2004 251 265
226. H.R. Brodt, B.S. Kamps, E.B. Helm, H. Schofer, and P. Mitrou Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival AIDS 12 1998 1475 1481
227. P.S. Gill, A. Tulpule, B.M. Espina, S. Cabriales, J. Bresnahan, and M. Ilaw Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma J Clin Oncol 17 1999 1876 1883
228. A. Tulpule, J. Groopman, M.W. Saville, W. Harrington Jr., A. Friedman-Kien, and B.M. Espina Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma Cancer 95 2002 147 154
229. G. Nasti, D. Errante, R. Talamini, G. Rizzardini, M. Fasan, and G. Landonio Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study J Clin Oncol 18 2000 1550 1557
230. A. Torresin, G. Cassola, G. Penco, M.P. Crisalli, and N. Piersantelli Vinca alkaloids and macrolides in human immunodeficiency virus-related malignancies: a safe association Cancer Chemother Pharmacol 39 1996 176 177
231. D.E. Hernandez, and J.R. Perez Advanced epidemic Kaposi's sarcoma: treatment with bleomycin or combination of doxorubicin, bleomycin, and vincristine Int J Dermatol 35 1996 831 833
232. P.S. Gill, M. Rarick, J.A. McCutchan, L. Slater, B. Parker, and E. Muchmore Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial Am J Med 90 1991 427 433
233. P. Gill, M. Rarick, M. Bernstein-Singer, M. Harb, B.M. Espina, and V. Shaw Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine Am J Clin Oncol 13 1990 315 319
234. D.T. Scadden, H.A. Bering, J.D. Levine, J. Bresnahan, L. Evans, and C. Epstein GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma Am J Clin Oncol 14 Suppl 1 1991 S40 S44
235. P.S. Gill, R.T. Mitsuyasu, T. Montgomery, J. Huang, S. Cabriales, and M. Testa AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma Cancer J Sci Am 3 1997 278 283
236. S. Stewart, H. Jablonowski, F.D. Goebel, K. Arasteh, M. Spittle, and A. Rios Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group J Clin Oncol 16 1998 683 691
237. P.S. Gill, J. Wernz, D.T. Scadden, P. Cohen, G.M. Mukwaya, and J.H. von Roenn Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma J Clin Oncol 14 1996 2353 2364
238. J.F. Money-Kyrle, F. Bates, J. Ready, B.G. Gazzard, R.H. Phillips, and F.C. Boag Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study Clin Oncol (R Coll Radiol) 5 1993 367 371
239. F.M. Muggia Liposomal encapsulated anthracyclines: new therapeutic horizons Curr Oncol Rep 3 2001 156 162
240. M. Nunez, P. Saballs, M.E. Valencia, J. Santos, E. Ferrer, and I. Santos Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy HIV Clin Trials 2 2001 429 437
241. U.R. Hengge, N.H. Brockmeyer, M. Baumann, G. Reimann, and M. Goos Liposomal doxorubicin in AIDS-related Kaposi's sarcoma Lancet 342 1993 497
242. C. Pfrommer, B. Tebbe, C.A. Tidona, U. Wolfer, S. Krengel, and H. Zeichardt Progressive HHV-8-positive classic Kaposi's sarcoma: rapid response to interferon alpha-2a but persistence of HHV-8 DNA sequences in lesional skin Br J Dermatol 139 1998 516 519
243. S.E. Krown Management of Kaposi sarcoma: the role of interferon and thalidomide Curr Opin Oncol 13 2001 374 381
244. P. Kondlapoodi Interferon in the treatment of Kaposi's sarcoma N Engl J Med 309 1983 923 924
245. R.A. Soler, M. Howard, N.S. Brink, D. Gibb, R.S. Tedder, and D. Nadal Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide Clin Infect Dis 23 1996 501 503 discussion, 504-5
246. R.F. Little, K.M. Wyvill, J.M. Pluda, L. Welles, V. Marshall, and W.D. Figg Activity of thalidomide in AIDS-related Kaposi's sarcoma J Clin Oncol 18 2000 2593 2602
247. P. Saiag, M. Pavlovic, T. Clerici, V. Feauveau, J.C. Nicolas, and D. Emile Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA AIDS 12 1998 2169 2176
248. P.S. Gill, B.M. Espina, T. Moudgil, S. Kidane, J.A. Esplin, and A. Tulpule All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study Leukemia 8 Suppl 3 1994 S26 S32
249. T. Simonart, J.P. Van Vooren, and S. Meuris Treatment of Kaposi's sarcoma with human chorionic gonadotropin Dermatology 204 2002 330 333
250. J.D. Hillman, A.T. Peng, A.C. Gilliam, and S.C. Remick Treatment of Kaposi sarcoma with oral administration of shark cartilage in a human herpesvirus 8-seropositive, human immunodeficiency virus-seronegative homosexual man Arch Dermatol 137 2001 1149 1152
251. J.H. Von Roenn Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma Hematol Oncol Clin North Am 17 2003 747 762
252. F. Geara, J.P. Le Bourgeois, P. Piedbois, J.M. Pavlovitch, and J.J. Mazeron Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma Int J Radiat Oncol Biol Phys 21 1991 1517 1522
253. J.S. Cooper, P.R. Fried, and L.J. Laubenstein Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma JAMA 252 1984 934 935
254. D. Margaretic, D. Faj, I. Tomas, B. Dmitrovic, and Z. Krajina Total skin electron treatment of extensive cutaneous lesions in Kaposi sarcoma Croat Med J 43 2002 342 345
255. V.G. Schweitzer Photodynamic therapy improves Kaposi's sarcoma in AIDS patients Am Fam Physician 38 1988 260
256. Z.P. Bernstein, B.D. Wilson, A.R. Oseroff, C.M. Jones, S.E. Dozier, and J.S. Brooks Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma AIDS 13 1999 1697 1704
257. J.W. Tappero, T.G. Berger, L.D. Kaplan, P.A. Volberding, and J.O. Kahn Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial J Acquir Immune Defic Syndr 4 1991 839 846
258. S. Shimomura, Y. Kikuchi, S. Oka, and J. Ishitoya Local treatment of AIDS-associated bulky Kaposi's sarcoma in the head and neck region Auris Nasus Larynx 27 2000 335 338
259. L. Brambilla, V. Boneschi, G. Beretta, and A.F. Finzi Intralesional chemotherapy for Kaposi's sarcoma Dermatologica 169 1984 150 155
260. J.B. Epstein, and C. Scully Intralesional vinblastine for oral Kaposi sarcoma in HIV infection Lancet 2 1989 1100 1101
261. A.A. Boudreaux, L.L. Smith, C.D. Cosby, M.M. Bason, J.W. Tappero, and T.G. Berger Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection J Am Acad Dermatol 28 1993 61 65
262. J.B. Epstein Treatment of oral Kaposi sarcoma with intralesional vinblastine Cancer 71 1993 1722 1725
263. G. Ghyka, M. Alecu, F. Halalau, and G. Coman Intralesional human leukocyte interferon treatment alone or associated with IL-2 in non-AIDS related Kaposi's sarcoma J Dermatol 19 1992 35 39
264. J. Dupuy, M. Price, G. Lynch, S. Bruce, and M. Schwartz Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma J Am Acad Dermatol 28 1993 966 972
265. P.S. Gill, Y. Lunardi-Ishkandar, S. Louie, A. Tulpule, T. Zheng, and B.M. Espina The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma N Engl J Med 335 1996 1261 1269
266. S. Walmsley, D.W. Northfelt, B. Melosky, M. Conant, A.E. Friedman-Kien, and B. Wagner Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group J Acquir Immune Defic Syndr 22 1999 235 246
267. M.J. Cannon, A.S. Laney, and P.E. Pellett Human herpesvirus 8: current issues Clin Infect Dis 37 2003 82 87
268. D.F. Martin, B.D. Kuppermann, R.A. Wolitz, A.G. Palestine, H. Li, and C.A. Robinson Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group N Engl J Med 340 1999 1063 1070
269. A. Mocroft, M. Youle, B. Gazzard, J. Morcinek, R. Halai, and A.N. Phillips Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group AIDS 10 1996 1101 1105
270. M.J. Glesby, D.R. Hoover, S. Weng, N.M. Graham, J.P. Phair, and R. Detels Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study J Infect Dis 173 1996 1477 1480
271. S.A. Spector, G.F. McKinley, J.P. Lalezari, T. Samo, R. Andruczk, and S. Follansbee Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group N Engl J Med 334 1996 1491 1497
272. R. Robles, D. Lugo, L. Gee, and M.A. Jacobson Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS J Acquir Immune Defic Syndr Hum Retrovirol 20 1999 34 38
273. L. Morfeldt, and J. Torssander Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients Scand J Infect Dis 26 1994 749 752
274. S.E. Krown Therapy of AIDS-associated Kaposi's sarcoma: targeting pathogenetic mechanisms Hematol Oncol Clin North Am 17 2003 763 783